The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
The recent progress of isoxazole in medicinal chemistry
Open accessAbstract
Isoxazole compounds exhibit a wide spectrum of targets and broad biological activities. Developing compounds with heterocycle rings has been one of the trends. The integration of isoxazole ring can offer improved physical-chemical properties. Because of the unique profiles, isoxazole ring becomes a popular moiety in compounds design. In this review article, the major focus has been paid to the applications of isoxazole compounds in treating multiple diseases, including anticancer, antimicrobial, anti-inflammatory, etc. Strategies for compounds design for preclinical, clinical, and FDA approved drugs were discussed. Also, the emphasis has been addressed to the future perspectives and trend for the application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
The Antimicrobial Resistance Crisis: Causes, Consequences, and Management
Michael, C. A., Dominey-Howes, D., & Labbate, M. (2014) · Frontiers in Public Health · doi:10.3389/fpubh.2014.00145 · Cited by 974
Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4
Pettit, G. R., Singh, S. B., Hamel, E., Lin, C. M., Alberts, D. S., & Garcia-Kendal, D. (1989) · Experientia · doi:10.1007/bf01954881 · Cited by 786
The multifaceted roles of antibiotics and antibiotic resistance in nature
Sengupta, S., Chattopadhyay, M. K., & Grossart, H.-P. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00047 · Cited by 629
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Rossignol, J.-F. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.014 · Cited by 556
Isoxazole ring as a useful scaffold in a search for new therapeutic agents
Sysak, A., & Obmińska-Mrukowicz, B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.002 · Cited by 338
The Future of Antibiotics and Resistance: A Tribute to a Career of Leadership by John Bartlett
Spellberg, B., & Gilbert, D. N. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu392 · Cited by 324
Selvam, C., Jachak, S. M., Thilagavathi, R., & Chakraborti, A. K. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.039 · Cited by 309
Lilienkampf, A., Mao, J., Wan, B., Wang, Y., Franzblau, S. G., & Kozikowski, A. P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900003c · Cited by 308
Mirguet, O., Gosmini, R., Toum, J., Clément, C. A., Barnathan, M., Brusq, J.-M., Mordaunt, J. E., Grimes, R. M., Crowe, M., Pineau, O., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401088k · Cited by 305
Quinoline: A promising antitubercular target
Keri, R. S., & Patil, S. A. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.007 · Cited by 301
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Ali, I., Lone, M., Al-Othman, Z., Al-Warthan, A., & Sanagi, M. (2015) · Current Drug Targets · doi:10.2174/1389450116666150309115922 · Cited by 252
Antiviral Drugs for Viruses Other Than Human Immunodeficiency Virus
Razonable, R. R. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0309 · Cited by 241
Jensen, M. R., Schoepfer, J., Radimerski, T., Massey, A., Guy, C. T., Brueggen, J., Quadt, C., Buckler, A., Cozens, R., Drysdale, M. J., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr1996 · Cited by 229
3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
Hewings, D. S., Wang, M., Philpott, M., Fedorov, O., Uttarkar, S., Filippakopoulos, P., Picaud, S., Vuppusetty, C., Marsden, B., Knapp, S., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200640v · Cited by 216
A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and Invasion
Almahariq, M., Tsalkova, T., Mei, F. C., Chen, H., Zhou, J., Sastry, S. K., Schwede, F., & Cheng, X. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.080689 · Cited by 207
Shin, K. D., Lee, M.-Y., Shin, D.-S., Lee, S., Son, K.-H., Koh, S., Paik, Y.-K., Kwon, B.-M., & Han, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507209200 · Cited by 171
The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review
Shiro, T., Fukaya, T., & Tobe, M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.12.004 · Cited by 166
Ashwini, N., Garg, M., Mohan, C. D., Fuchs, J. E., Rangappa, S., Anusha, S., Swaroop, T. R., Rakesh, K. S., Kanojia, D., Madan, V., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.069 · Cited by 151
Sharp, S. Y., Prodromou, C., Boxall, K. J., Powers, M. V., Holmes, J. L., Box, G., Matthews, T. P., Cheung, K.-M. J., Kalusa, A., James, K. E., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0149 · Cited by 145
Musad, E. A., Mohamed, R., Saeed, B. A., Vishwanath, B. S., & Lokanatha, K. M. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.142 · Cited by 141
Mao, J., Yuan, H., Wang, Y., Wan, B., Pieroni, M., Huang, Q., van Breemen, R. B., Kozikowski, A. P., & Franzblau, S. G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900340a · Cited by 111
Management of uncomplicated urinary tract infections
Jancel, T. (2002) · Western Journal of Medicine · doi:10.1136/ewjm.176.1.51 · Cited by 105
Devel, L., Czarny, B., Beau, F., Georgiadis, D., Stura, E. A., & Dive, V. (2010) · Biochimie · doi:10.1016/j.biochi.2010.07.017 · Cited by 92
Azzali, E., Machado, D., Kaushik, A., Vacondio, F., Flisi, S., Cabassi, C. S., Lamichhane, G., Viveiros, M., Costantino, G., & Pieroni, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00793 · Cited by 86
Stochastic unit commitment with sub-hourly dispatch constraints
Wang, J., Wang, J., Liu, C., & Ruiz, J. P. (2013) · Applied Energy · doi:10.1016/j.apenergy.2013.01.008 · Cited by 82
Stable and Potent Analogues Derived from the Modification of the Dicarbonyl Moiety of Curcumin
Chakraborti, S., Dhar, G., Dwivedi, V., Das, A. K., Poddar, A., Chakraborti, G., Basu, G., Chakrabarti, P., Surolia, A., & Bhattacharyya, B. (2013) · Biochemistry · doi:10.1021/bi400734e · Cited by 72
Kumar, L., Verma, S., Bhardwaj, A., Vaidya, S., & Vaidya, B. (2013) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2013.769446 · Cited by 69
Llor, C., Moragas, A., Bayona, C., Morros, R., Pera, H., Plana‐Ripoll, O., Cots, J. M., & Miravitlles, M. (2013) · BMJ · doi:10.1136/bmj.f5762 · Cited by 63
BET inhibition as a new strategy for the treatment of gastric cancer
Montenegro, R. C., Clark, P. G. K., Howarth, A., Wan, X., Ceroni, A., Siejka, P., Nunez-Alonso, G. A., Monteiro, O., Rogers, C. M., Gamble, V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9766 · Cited by 61
Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents
Xue, N., Yang, X., Wu, R. F., Chen, J., He, Q., Yang, B., Lü, X., & Hu, Y. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.048 · Cited by 59
Banoğlu, E., Çelikoğlu, E., Völker, S., Olğaç, A., Gerstmeier, J., Garscha, U., Çalışkan, B., Schubert, U. S., Carotti, A., Macchiarulo, A., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.027 · Cited by 57
3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer
Rakesh, K. S., Jagadish, S., Balaji, K. S., Zameer, F., Swaroop, T. R., Mohan, C. D., Jayarama, S., & Rangappa, K. S. (2015) · Inflammation · doi:10.1007/s10753-015-0247-5 · Cited by 51
Reaction: A Role for Actinide Chemists
Taylor, R. J. (2016) · Chem · doi:10.1016/j.chempr.2016.10.004 · Cited by 51
2‐Amino‐3‐cyano‐4‐(5‐arylisoxazol‐3‐yl)‐4H‐chromenes: Synthesis and In Vitro Cytotoxic Activity
Akbarzadeh, T., Rafinejad, A., Mollaghasem, J. M., Safavi, M., Fallah‐Tafti, A., Pordeli, M., Ardestani, S. K., Shafiee, A., & Foroumadi, A. (2012) · Archiv der Pharmazie · doi:10.1002/ardp.201100345 · Cited by 48
Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
Jain, P. P., Degani, M. S., Raju, A., Anantram, A., Seervi, M., Sathaye, S. S., Ray, M., & Rajan, M. G. R. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.11.057 · Cited by 47
Sun, J. L., Lin, C., Qin, X., Dong, X., Tu, Z., Tang, F., Chen, C., & Zhang, J. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.009 · Cited by 40
Ananda, H., Kumar, K. S. S., Hegde, M. B., & Rangappa, K. S. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2777-z · Cited by 40
Discovery of potent N-(isoxazol-5-yl)amides as HSP90 inhibitors
Chen, D., Shen, A., Li, J., Shi, F., Chen, W., Ren, J., Liu, H., Xu, Y., Wang, X., Yang, X., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.065 · Cited by 39
Identification of HDAC6‐Selective Inhibitors of Low Cancer Cell Cytotoxicity
Gaisina, I. N., TUECKMANTEL, W., Ugolkov, A. V., Shen, S., Hoffen, J., Dubrovskyi, O., Mazar, A. P., Schoon, R. A., Billadeau, D. D., & Kozikowski, A. P. (2015) · ChemMedChem · doi:10.1002/cmdc.201500456 · Cited by 39
Zhang, C., Wang, X., Liu, H., Zhang, M., Geng, M., Sun, L., Shen, A., & Zhang, A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.043 · Cited by 39
Design, synthesis and biological evaluation of diaziridinyl quinone isoxazole hybrids
Swapnaja, K. J. M., Yennam, S., Chavali, M. S., Poornachandra, Y., Kumar, C. G., Muthusamy, K., Jayaraman, V. B., Arumugam, P., Sridhar, B., & Sriram, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.042 · Cited by 38
KRIBB3, a novel microtubule inhibitor, induces mitotic arrest and apoptosis in human cancer cells
Shin, K. D., Yoon, Y. J., Kang, Y.-R., Son, K., Kim, H. M., Kwon, B., & Han, D. C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.027 · Cited by 37
Mohareb, R. M., El-Sayed, N. N. E., & Abdelaziz, M. A. (2013) · Steroids · doi:10.1016/j.steroids.2013.08.007 · Cited by 34
Yoon, H., Kwak, Y., Choi, S.-H., Cho, H., Kim, N. D., & Sim, T. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01522 · Cited by 33
Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90
Baruchello, R., Simoni, D., Grisolia, G., Barbato, G., Marchetti, P., Rondanin, R., Mangiola, S., Giannini, G., Brunetti, T., Alloatti, D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201155e · Cited by 33
Scheinfeld, N. S. (2016) · Dermatology Online Journal · doi:10.5070/d3226031313 · Cited by 26
Shaw, J., Chen, B., Bourgault, J. P., Jiang, H., Kumar, N., Mishra, J., Valeriote, F. A., Media, J., Bobbitt, K. R., Pietraszkiewicz, H., et al. (2012) · American Journal of Biomedical Sciences · doi:10.5099/aj120100014 · Cited by 21
HIV-1 genetic variation and drug resistance development
Megens, S., & Laethem, K. V. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2013.844649 · Cited by 19
Preclinical antitumor activity of SST0116CL1: A novel heat shock protein 90 inhibitor
Vesci, L., Milazzo, F. M., Carollo, V., Pace, S., & GIANINI, G. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2575 · Cited by 8
Metadata
- Authors
- Zhu, J., Mo, J., Lin, H.-Z., Chen, Y., & Sun, H.-P.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 26
- Issue
- 12
- Pages
- 3065-3075
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2806424166
- Cited by
- 417
- References
- 51
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.